BioNTech and DualityBio will develop cancer drugs worth more than $1.5 billion

Published Date: 08 Apr 2023

German company BioNTech said on Monday that it has signed an agreement with Chinese biotech company DualityBio to jointly develop and commercialize two cancer drug candidates.

Read Full News

Latest News

Boehringer Ingelheim Launches AI Centre for Pharma Research in London

German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning ⁠in London, it said on Monday, as it seeks to expand its AI...

How Much Do Long Wait Times Cost Canadian Patients?

Long wait times for surgery and medical treatment cost Canadians over $4.2 billion in lost wages and productivity in 2025.

Virtual Physiotherapy Shows Promise for Chronic Cough

A single 1-hour virtual group physiotherapy intervention for chronic cough achieves high uptake and reduces cough severity and frequency.

Germans Trust ‘Dr AI’ More Than Doctors Who Use It

Nearly half of Germans consult AI before seeing a physician, and some rate chatbot advice as equal to a medical second opinion.

Neurology Clinics are Adopted by Genetic Therapies.

There are new treatments for genetic neuromuscular diseases in the works, which will present challenges for neurologists as well as opportunities for patients.

Thermo Fisher Issues a Warning About the Squeeze in Biotech Funding.

Indicating that biotechs' lack of interest in using Thermo Fisher Scientific's services to create treatments and vaccines may last into the following year, the company released a statement on Wednesday.

Todays Updates

NP-Led Outreach Ups Cancer Screening in Rural Women Veterans

A nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.

Less Mental Decline With Darolutamide vs Enzalutamide in PC

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Todays Updates

NP-Led Outreach Ups Cancer Screening in Rural Women Veterans

A nurse practitioner-led outreach program improves the rates of breast and cervical cancer screening among women veterans in rural areas, a retrospective study shows.

Less Mental Decline With Darolutamide vs Enzalutamide in PC

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

Latest News

German drugmaker Boehringer Ingelheim is launching a centre for artificial intelligence and machine learning ⁠in London, it said on Monday, as it seeks to expand its AI...

Long wait times for surgery and medical treatment cost Canadians over $4.2 billion in lost wages and productivity in 2025.

A single 1-hour virtual group physiotherapy intervention for chronic cough achieves high uptake and reduces cough severity and frequency.

Nearly half of Germans consult AI before seeing a physician, and some rate chatbot advice as equal to a medical second opinion.

There are new treatments for genetic neuromuscular diseases in the works, which will present challenges for neurologists as well as opportunities for patients.

Indicating that biotechs' lack of interest in using Thermo Fisher Scientific's services to create treatments and vaccines may last into the following year, the company released a statement on Wednesday.

News All Time

Hippocratic AI Raises Funds to Create Healthcare Models.

A startup developing artificial intelligence models for the healthcare sector, Hippocratic AI, has raised $50 million in a larger-than-normal seed funding round.

WHO Issues Warning Against Misinformation When Using AI in Healthcare.

On Tuesday, the World Health Organization warned against using AI in public healthcare because the data it uses to make decisions may be biased or misapplied.

US Jury Rules in Favor of Natera in Cancer-Detection Patent Case.

Monday, a federal jury in Delaware was persuaded to award genetic testing company Natera Inc. $19.3 million in damages from Invitae Corp.'s ArcherDX for infringing patents pertaining to cancer detection.

Changes in Hypertrophic Cardiomyopathy Risk Stratification?

Data show that compared to 24-hour monitoring, extended ECG monitoring detects a higher incidence of clinically relevant arrhythmias.

New Trials in Breast Cancer: Could Your Patient Benefit?

Perhaps one of your patients qualifies to participate in a clinical trial that is currently looking for breast cancer patients.

The Musk Animal Testing Panel Is Riddled With Possibilities.

A board overseeing animal research has been staffed by insiders from Elon Musk's brain-implant business who could profit financially as the company advances.

Drugmakers increase their research spending and look for deals.

As the larger players in the sector look for new sources of long-term revenue, drugmakers announced on Thursday that they are open to acquisitions and that their R&D spending has increased.

EU Law Reform Could Lead to a Shift in Investments: GSK.

The European Union's pharmaceutical industry is governed by new laws, which the British pharmaceutical company GSK warned on Wednesday run the risk of driving businesses to innovate and invest elsewhere.

Proposed Drug Law Reforms Published by the EU.

On Wednesday, Brussels released a long-awaited draft of its proposed overhaul of the laws governing the pharmaceutical industry in the European Union, setting off a dispute with drugmakers who threaten to invest and innovate elsewhere.

Musk's brain transplant company seeks human collaboration

Elon Musk's neuroimplantation company Neuralink has reached one of the largest neurosurgical centers in the country capable of testing partners as it plans to test human devices if the regulator.

FDA moves to quickly approve gene therapy

The FDA is making important changes to gene therapy development, including encouraging the use of biomarkers that help recommend treatments for serious conditions, FDA officials said.

AI pab kwv yees ulcerative colitis remission/activity, relapse.

AI tools can distinguish between functional and histological clearance and predict the severity of ulcerative colitis biopsies, and can play a role in clinical trials and routine practice.

The fall of SVB casts a shadow over the beginnings of American biotechnology

The Silicon Valley banking meltdown will leave biotech start-ups with different funding options, investors and analysts said Monday.

SVB shock could have chilling effect on UK biotech sector

HSBC's bailout of the UK branch of the Silicon Valley bank has saved Britain's main biotech sector from collapse, but funding a sector the government sees as essential for the growth of the future economy could be affected, according to industry executives.

The risk of stent infection is low but can be reported

A review of stent coronary artery disease has led researchers to question whether these events are underreported.

Prucalopride an Effective Adjunct for Colonoscopy Bowel Prep

A single dose of prucalopride given before a polyethylene glycol bowel prep regimen improves the quality of bowel cleansing in patients scheduled for elective colonoscopy.

Recommended News For You

La interacción GBP3-STING en el glioblastoma coordina la respuesta deficiente al temozolomide.

Reducing social media to an hour a day boosts young people's self-image.

In prostate cancer survivorship, sleep disturbances are underappreciated.

ASTRO Guideline Addresses Specifics of HPV-Associated Oropharyngeal Cancer

Sickle Cell Disease Drug Pulled From Global Markets

The response of bipolar patients to lithium may be predicted by ancestry.

Parkinson patient's gait is restored by a spinal cord stimulator.

Recommended Articles For You

Lymphomatoid Papulosis: What You Need to Know 

Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies 

Cancer Staging: Updates, Clinical Insights, and Educational Resources for Medical Professionals 

Introduction To Immune Thrombocytopenic Purpura 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.

2.

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

3.

FINAL USPSTF RECOMMENDATIONS ON ANXIETY, DEPRESSION, AND SUIICIDAL RISK.

4.

Durvalumab Wins FDA Approval in Limited-Stage SCLC

5.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

1.

Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology

2.

CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights

3.

Personalized Cancer Vaccines: The Next Frontier in Precision Oncology

4.

AI Meets the Gut Microbiome: Early Detection of GI Malignancies Redefined

5.

How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

2.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

3.

Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

5.

Navigating the Complexities of Ph Negative ALL - Part XI

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot